CENTENE CORP CNC

Latest FY: 2025 Healthcare Healthcare Plans
Market Price $67.48
Market Cap $32.61B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑19.4% YoY
$194.78B
3-Yr CAGR: 12.9%
Net Income ↓-301.9% YoY
-$6.67B
Net Margin: -3.4%
Free Cash Flow ↑981.8% YoY
$4.32B
FCF Yield: 13.25%
EPS (Diluted) ↓-314.4% YoY
$-13.53
Basic: $-13.53
Return on Equity Efficiency
-33.4%
ROA: -8.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CNC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $40,607.0M $4,936.0M $562.0M $1.72 $1,851.0M $1,545.0M
FY 2017 $48,382.0M +19.1% $5,645.0M $828.0M +47.3% $2.35 +36.7% $1,489.0M $1,067.0M -30.9%
FY 2018 $56,435.0M +16.6% $7,992.0M $900.0M +8.7% $1.13 -51.8% $1,234.0M $559.0M -47.6%
FY 2019 $70,364.0M +24.7% $9,037.0M $1,321.0M +46.8% $3.14 +177.9% $1,483.0M $753.0M +34.7%
FY 2020 $103,800.0M +47.5% $14,233.0M $1,808.0M +36.9% $3.12 -0.6% $5,503.0M $4,634.0M +515.4%
FY 2021 $117,983.0M +13.7% $14,487.0M $1,347.0M -25.5% $2.28 -26.9% $4,205.0M $3,295.0M -28.9%
FY 2022 $135,479.0M +14.8% $16,918.0M $1,202.0M -10.8% $2.07 -9.2% $6,261.0M $5,257.0M +59.5%
FY 2023 $153,999.0M +13.7% $17,637.0M $2,702.0M +124.8% $4.95 +139.1% $8,053.0M $7,254.0M +38.0%
FY 2024 $163,071.0M +5.9% $17,069.0M $3,305.0M +22.3% $6.31 +27.5% $154.0M $-490.0M -106.8%
FY 2025 $194,777.0M +19.4% $14,209.0M $-6,674.0M -301.9% $-13.53 -314.4% $5,088.0M $4,321.0M +981.8%
$

Valuation

Market Price $67.48
Market Cap $32.61B
Enterprise Value $32.12B
P/E Ratio N/A
P/B Ratio 1.67
FCF Yield 13.25%
Dividend Yield N/A
Shares Outstanding 493,797,000
%

Profitability & Margins

Gross Margin 7.30%
Operating Margin -3.91%
Net Margin -3.43%
Return on Equity (ROE) -33.45%
Return on Assets (ROA) -8.70%
Asset Turnover 2.54x
Revenue 3-Yr CAGR 12.86%
🛡️

Financial Health & Liquidity

Current Ratio 1.10
Cash Ratio 0.49
Debt / Equity 0.872
Debt / Assets 0.227
Cash & Equivalents $17.89B
Total Debt $17.40B
Book Value / Share $40.41
💧

Cash Flow Efficiency

Operating Cash Flow $5.09B
Capital Expenditures (CapEx) $767.00M
Free Cash Flow $4.32B
OCF / Revenue 2.61%
FCF / Revenue 2.22%
FCF 3-Yr CAGR -6.33%
🏷️

Per Share Metrics

EPS (Diluted) $-13.53
EPS (Basic) $-13.53
Dividends / Share N/A
Book Value / Share $40.41
EPS YoY Growth -314.42%
🏛️

Balance Sheet (FY 2025)

Total Assets $76.75B
Total Liabilities $56.69B
Stockholders' Equity $19.95B
Current Assets $40.37B
Current Liabilities $36.70B